Prescription Required
Pegstim 6mg Prefilled Syringe 0.6ml contains Pegfilgrastim (6mg), a granulocyte colony-stimulating factor (G-CSF) used to reduce the risk of infection in patients undergoing chemotherapy that may cause neutropenia—a condition characterized by low levels of neutrophils, a type of white blood cell essential for fighting infections. By stimulating the bone marrow to produce more neutrophils, Pegstim helps maintain adequate white blood cell counts, thereby enhancing the body's defense against infections during cancer treatment.
Administered via a prefilled syringe, Pegstim offers a convenient and precise dosing method, ensuring patients receive the correct amount of medication. Its formulation allows for once-per-chemotherapy cycle administration, simplifying the treatment regimen for both patients and healthcare providers. Pegstim is typically given as a subcutaneous injection, either by a healthcare professional or by the patient or caregiver after appropriate training.
Patients with liver impairment should inform their healthcare provider before starting Pegstim, as dose adjustments or additional monitoring may be necessary.
Patients with kidney impairment should inform their healthcare provider before starting Pegstim, as dose adjustments or additional monitoring may be necessary.
While there is no direct interaction between Pegstim and alcohol, it's advisable to limit alcohol consumption during chemotherapy, as it can weaken the immune system and exacerbate side effects.
Pegstim is not known to impair the ability to drive or operate machinery. However, if you experience dizziness or any adverse effects that could affect concentration, refrain from such activities.
The safety of Pegfilgrastim during pregnancy has not been established. Pregnant women should only use Pegstim if clearly needed and prescribed by their healthcare provider.
It is unknown whether Pegfilgrastim passes into breast milk. Nursing mothers should consult their doctor before starting Pegstim to weigh potential risks and benefits.
Pegstim contains Pegfilgrastim, a long-acting form of filgrastim, which is a recombinant human granulocyte colony-stimulating factor (G-CSF). Pegfilgrastim stimulates the bone marrow to increase the production of neutrophils, thereby reducing the duration of neutropenia in patients undergoing chemotherapy. The pegylation of filgrastim extends its half-life, allowing for a sustained effect with less frequent dosing. By maintaining adequate neutrophil levels, Pegstim helps decrease the risk of infection and supports the immune system during periods of immunosuppression caused by chemotherapy.
If you miss a scheduled dose:
Neutropenia is a condition characterized by a low level of neutrophils, a type of white blood cell responsible for fighting infections. It commonly occurs as a side effect of chemotherapy, as these treatments target rapidly dividing cells, including those in the bone marrow.
Pegstim 6mg Prefilled Syringe 0.6ml (Pegfilgrastim) is a long-acting medication used to prevent neutropenia in cancer patients undergoing chemotherapy. It works by stimulating neutrophil production, reducing the risk of infections. Administered as a subcutaneous injection once per chemotherapy cycle, Pegstim provides a convenient and effective way to maintain immune health. Patients should follow proper storage and administration guidelines and monitor for any side effects or allergic reactions. Regular consultations with a doctor are essential to ensure the safe and effective use of Pegstim.
Content Updated on
Wednesday, 26 Feburary, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA